Generation Bio Asset Turnover 2020-2023 | GBIO
Generation Bio asset turnover from 2020 to 2023. Asset turnover can be defined as the amount of sales or revenues generated per dollar of assets. The asset turnover ratio is an indicator of the efficiency with which a company is deploying its assets.
| Generation Bio Asset Turnover Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.211B | $0.006B |
| Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.673B | 5.66 |
| Dr Reddy's Laboratories (RDY) | India | $12.551B | 19.84 |
| Aspen Pharmacare (APNHY) | South Africa | $5.574B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $5.208B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $2.858B | 2.18 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.042B | 14.20 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.695B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.481B | 0.00 |
| Personalis (PSNL) | United States | $0.078B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.072B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.028B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.024B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |